Syneron-Candela Unveils New Technology and Indications at AAD Annual Meeting

Syneron-Candela revealed updates to its GentleTouch, PicoWay and Profound technologies during the 2017 American Academy of Dermatology (AAD) meeting in Orlando, Florida.

The GentleTouch solid-state laser system has added CE mark approval to its FDA clearance and joins the company’s portfolio as the only device to combine alexandrite and radiofrequency (RF) energies for hair reduction. The system includes patent-pending EverCool, a contact-cooling method cleared for hair removal on all skin types.

The PicoWay, indicated for tattoo removal and treatment of benign pigmented lesions, received FDA clearance for the treatment of acne scars in Fitzpatrick Skin Types II-V using the Resolve holographic 1064nm wavelength handpiece.

The Profound fractional RF microneedling device was recently FDA cleared to improve the appearance of cellulite: The 25º Dermal handpiece and cartridge are used for percutaneous treatment of facial wrinkles, and the 75º SubQ handpiece and cartridge are used to improve the appearance of cellulite in patients with Fitzpatrick Skin Types I-III.